Fundacion Miguel Servet Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT04600453
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundacion Miguel Servet | Fundación Miguel Servet/Navarrabiomed